294 related articles for article (PubMed ID: 35444556)
1. Ethnic Diversity and Warfarin Pharmacogenomics.
Asiimwe IG; Pirmohamed M
Front Pharmacol; 2022; 13():866058. PubMed ID: 35444556
[TBL] [Abstract][Full Text] [Related]
2. Warfarin Pharmacogenomics in Diverse Populations.
Kaye JB; Schultz LE; Steiner HE; Kittles RA; Cavallari LH; Karnes JH
Pharmacotherapy; 2017 Sep; 37(9):1150-1163. PubMed ID: 28672100
[TBL] [Abstract][Full Text] [Related]
3. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
[TBL] [Abstract][Full Text] [Related]
4. Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.
Cavallari LH; Shin J; Perera MA
Pharmacotherapy; 2011 Dec; 31(12):1192-207. PubMed ID: 22122181
[TBL] [Abstract][Full Text] [Related]
5. Genotype-guided warfarin therapy: current status.
Tavares LC; Marcatto LR; Santos PCJL
Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
[TBL] [Abstract][Full Text] [Related]
6. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2013 Jun; 35(3):359-68. PubMed ID: 21052837
[TBL] [Abstract][Full Text] [Related]
8. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
[TBL] [Abstract][Full Text] [Related]
9. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
Johnson JA; Gong L; Whirl-Carrillo M; Gage BF; Scott SA; Stein CM; Anderson JL; Kimmel SE; Lee MT; Pirmohamed M; Wadelius M; Klein TE; Altman RB;
Clin Pharmacol Ther; 2011 Oct; 90(4):625-9. PubMed ID: 21900891
[TBL] [Abstract][Full Text] [Related]
10. Warfarin dosing algorithms: A systematic review.
Asiimwe IG; Zhang EJ; Osanlou R; Jorgensen AL; Pirmohamed M
Br J Clin Pharmacol; 2021 Apr; 87(4):1717-1729. PubMed ID: 33080066
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic dosing of warfarin: ready or not?
Lackner TE
Consult Pharm; 2008 Aug; 23(8):614-9. PubMed ID: 19032008
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of AIDS in Asian and Pacific Islander populations in San Francisco.
Woo JM; Rutherford GW; Payne SF; Barnhart JL; Lemp GF
AIDS; 1988 Dec; 2(6):473-5. PubMed ID: 3149494
[TBL] [Abstract][Full Text] [Related]
13. Warfarin pharmacogenomics.
Cavallari LH; Limdi NA
Curr Opin Mol Ther; 2009 Jun; 11(3):243-51. PubMed ID: 19479657
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
[TBL] [Abstract][Full Text] [Related]
15. The effects of race and ethnicity on thyroid cancer incidence.
Magreni A; Bann DV; Schubart JR; Goldenberg D
JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):319-23. PubMed ID: 25654447
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic evaluation of warfarin pharmacogenomics.
You JH
Expert Opin Pharmacother; 2011 Feb; 12(3):435-41. PubMed ID: 21231897
[TBL] [Abstract][Full Text] [Related]
17. Warfarin pharmacogenomics in children.
Vear SI; Stein CM; Ho RH
Pediatr Blood Cancer; 2013 Sep; 60(9):1402-7. PubMed ID: 23682017
[TBL] [Abstract][Full Text] [Related]
18. Racial/Ethnic Disparities in Tobacco Product Use Among Middle and High School Students - United States, 2014-2017.
Odani S; Armour BS; Agaku IT
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):952-957. PubMed ID: 30161103
[TBL] [Abstract][Full Text] [Related]
19. Warfarin dosing and the promise of pharmacogenomics.
Dumas TE; Hawke RL; Lee CR
Curr Clin Pharmacol; 2007 Jan; 2(1):11-21. PubMed ID: 18690851
[TBL] [Abstract][Full Text] [Related]
20. The Diversity Snowball Effect: The Quest to Increase Diversity in Emergency Medicine: A Case Study of Highland's Emergency Medicine Residency Program.
Garrick JF; Perez B; Anaebere TC; Craine P; Lyons C; Lee T
Ann Emerg Med; 2019 Jun; 73(6):639-647. PubMed ID: 30902450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
